Outset Medical (OM) Short term Debt (2019 - 2022)
Outset Medical's (OM) quarterly Short term Debt came in at $1.0 million in Q2 2022, down 86.67% quarter-over-quarter from $7.5 million in Q4 2019.
Powered by 
Analysis
Outset Medical (OM) Short term Debt (2019 - 2022) Analysis & Trends
Outset Medical (OM) has reported Short term Debt for 2 consecutive years, with $1.0 million the latest figure, recorded in Q2 2022.
- On a quarterly basis, Short term Debt changed N/A year-over-year to $1.0 million in Q2 2022; TTM through Jun 2022 was $1.0 million, a N/A change from a year earlier, with the FY2019 full-year figure at $7.5 million, changed N/A from the prior year.
- Short term Debt was $1.0 million for Q2 2022 at Outset Medical, down from $7.5 million in the prior quarter.
- Over five years, Short term Debt peaked at $7.5 million in Q4 2019 and troughed at $1.0 million in Q2 2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.85 Bn | 174.25 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 127.70 Bn | 122.49 Bn | 1.96 Bn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn |
| 4 | Stryker | 103.83 Bn | 100.35 Bn | 4.50 Bn |
| 5 | Boston Scientific | 63.05 Bn | 62.51 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.81 Bn | 45.55 Bn | 1.35 Bn |
| 7 | Alcon | 32.94 Bn | 31.48 Bn | 1.68 Bn |
| 8 | Dexcom | 32.24 Bn | 30.29 Bn | 830.00 Mn |
| 9 | Steris | 20.71 Bn | 20.23 Bn | 684.20 Mn |
| 10 | Outset Medical | 59.95 Mn | -203.24 Mn | 13.28 Mn |